02:17 PM EDT, 09/12/2024 (MT Newswires) -- Fulcrum Therapeutics ( FULC ) shares plunged 60% after the company said its phase 3 trial evaluating losmapimod in patients with facioscapulohumeral muscular dystrophy failed to achieve its primary endpoint compared with placebo.

Intraday volume topped 29.2 million shares versus the daily average of about 938,000.

CN Energy ( CNEY ) said late Wednesday it was notified of noncompliance with the Nasdaq Stock Market's listing rules.

The shares slumped 47% as volume topped 13.8 million versus the daily average of almost 5.76 million.

Syra Health ( SYRA ) said late Wednesday it priced a public offering of securities to raise $2.1 million.

The stock plunged 49% with volume topping 3.69 million versus the daily average of about 138,000.

Price: 3.50, Change: -5.35, Percent Change: -60.45